We are live on ! Find out more
CIS

Capital International Sarl Portfolio holdings

AUM $6.11B
1-Year Est. Return 32.29%
This Fund
S&P 500
This Quarter Est. Return
-10.61%
1 Year Est. Return
+32.29%
3 Year Est. Return
+120.6%
5 Year Est. Return
+165.23%
10 Year Est. Return
+684.77%
AUM
$831M
AUM Growth
-$219M
Cap. Flow
-$66.6M
Cap. Flow %
-8.02%
Top 10 Hldgs %
27.73%
Holding
142
New
16
Increased
30
Reduced
51
Closed
5

Top Buys

Rank Stock Value
1
TCOM icon
Trip.com Group
TCOM
+$9.27M
2
ONC
BeOne Medicines Ltd
ONC
+$8.92M
3
GGB icon
Gerdau
GGB
+$4.12M
4
EOG icon
EOG Resources
EOG
+$3.96M
5
SLB icon
SLB Ltd
SLB
+$3.92M

Top Sells

Rank Stock Value
1
AES icon
AES
AES
+$21.4M
2
VALE icon
Vale
VALE
+$12.9M
3
AMX icon
America Movil
AMX
+$7.85M
4
CME icon
CME Group
CME
+$7.52M
5
AVGO icon
Broadcom
AVGO
+$6.51M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.62%
2 Technology 14.48%
3 Financials 12.79%
4 Communication Services 11.9%
5 Healthcare 9.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WAB icon
76
Wabtec
WAB
$49.3B
$3.42M 0.41%
48,760
– –
BKNG icon
77
Booking.com
BKNG
$161B
$3.36M 0.4%
48,775
-40,525
-45% -$2.97M
NEM icon
78
Newmont
NEM
$119B
$3.25M 0.39%
+93,720
New +$3.04M
DB icon
79
Deutsche Bank
DB
$71.5B
$3.24M 0.39%
406,829
– –
CCI icon
80
Crown Castle
CCI
$32.2B
$3.21M 0.39%
29,595
+10,795
+57% +$1.19M
HXL icon
81
Hexcel
HXL
$7.82B
$3.17M 0.38%
55,300
-20,800
-27% -$1.25M
RARE icon
82
Ultragenyx Pharmaceutical
RARE
$2.55B
$3.09M 0.37%
71,100
-11,900
-14% -$650K
ETN icon
83
Eaton
ETN
$174B
$3.08M 0.37%
44,899
-40,637
-48% -$3.04M
PM icon
84
Philip Morris
PM
$295B
$3.06M 0.37%
45,882
+3,690
+9% +$308K
AZN icon
85
AstraZeneca
AZN
$250B
$2.98M 0.36%
39,275
-11,100
-22% -$867K
JPM icon
86
JPMorgan Chase
JPM
$950B
$2.97M 0.36%
30,453
-3,800
-11% -$405K
SIVB
87
DELISTED
SVB Financial Group
SIVB
$2.96M 0.36%
15,600
– –
LVS icon
88
Las Vegas Sands
LVS
$29.6B
$2.81M 0.34%
53,925
-21,800
-29% -$1.18M
EEFT icon
89
Euronet Worldwide
EEFT
$2.7B
$2.7M 0.32%
26,330
-29,920
-53% -$3.31M
CB icon
90
Chubb
CB
$135B
$2.69M 0.32%
20,790
– –
STT icon
91
State Street
STT
$50.7B
$2.56M 0.31%
40,506
– –
AVP
92
DELISTED
Avon Products, Inc.
AVP
$2.48M 0.3%
1,630,400
-127,400
-7% -$244K
ACN icon
93
Accenture
ACN
$108B
$2.37M 0.29%
16,798
– –
YUM icon
94
Yum! Brands
YUM
$41.1B
$2.33M 0.28%
25,400
– –
WYNN icon
95
Wynn Resorts
WYNN
$10.6B
$2.28M 0.27%
23,030
– –
BNY
96
Bank of New York Mellon
BNY
$107B
$2.24M 0.27%
47,552
– –
RTX icon
97
RTX Corp
RTX
$301B
$2.18M 0.26%
32,575
+9,534
+41% +$748K
MDT icon
98
Medtronic
MDT
$112B
$2.13M 0.26%
23,400
– –
WFT
99
DELISTED
Weatherford International plc
WFT
$2.08M 0.25%
3,714,900
– –
GOL
100
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$2.05M 0.25%
+151,600
New +$1.53M
2 3
4
5 6

Similar funds

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Capital International Sarl's Q4 2018 Portfolio in Review

As of Q4 2018, Capital International Sarl held 142 positions worth $831M, down 21% from $1.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Capital International Sarl withdrew a net $66.6M in Q4 2018, closing 5 positions and reducing 51 holdings. Its most notable exit was Invesco, an estimated $2.91M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, Capital International Sarl opened a new position in BeOne Medicines Ltd worth $9.44M.

  • Capital International Sarl's largest Q4 2018 buy was BeOne Medicines Ltd: 67,300 shares worth $9.44M.
  • Capital International Sarl added most to Trip.com Group in Q4 2018, an estimated $9.27M increase.
  • Capital International Sarl's biggest Q4 2018 reduction was AES, cutting an estimated $21.4M.
  • Capital International Sarl fully exited Invesco in Q4 2018, selling an estimated $2.91M.
  • Capital International Sarl's ten largest holdings make up 28% of its $831M portfolio in Q4 2018.
  • Capital International Sarl opened 16 new positions and closed 5 in Q4 2018.
  • Capital International Sarl's portfolio value fell 21% quarter-over-quarter to $831M.

Based on Capital International Sarl's 13F filing for Q4 2018, filed 14 Feb 2019.